A road map for the treatment of pediatric diffuse midline glioma

被引：5

作者：

Koschmann, Carl ^{[1
]}

Al-Holou, Wajd N. ^{[1
]}

Alonso, Marta M. ^{[2
]}

Anastas, Jamie ^{[3
]}

Bandopadhayay, Pratiti ^{[4
]}

Barron, Tara ^{[5
]}

Becher, Oren ^{[6
]}

Cartaxo, Rodrigo ^{[1
]}

Castro, Maria G. ^{[1
]}

Chung, Chan ^{[7
]}

Clausen, Madison ^{[1
]}

Dang, Derek ^{[1
]}

Doherty, Robert ^{[1
]}

Duchatel, Ryan ^{[8
]}

Dun, Matthew ^{[8
]}

Filbin, Mariella ^{[4
]}

Franson, Andrea ^{[1
]}

Galban, Stefanie ^{[1
]}

Moure, Marc Garcia ^{[2
]}

Garton, Hugh ^{[1
]}

Gowda, Pruthvi ^{[4
]}

Marques, Joana Graca ^{[2
]}

Hawkins, Cynthia ^{[9
]}

Heath, Allison ^{[10
]}

Hulleman, Esther ^{[11
]}

Ji, Sunjong ^{[1
]}

Jones, Chris ^{[12
]}

Kilburn, Lindsay ^{[13
]}

Kline, Cassie ^{[10
]}

Koldobskiy, Michael A. ^{[14
]}

Lim, Daniel ^{[1
]}

Lowenstein, Pedro R. ^{[1
]}

Lu, Q. Richard ^{[16
,17
]}

Lum, Joanna ^{[1
]}

Mack, Stephen ^{[18
]}

Magge, Suresh ^{[1
]}

Marini, Bernard ^{[1
]}

Messinger, Dana ^{[1
]}

Martin, Donna ^{[1
]}

Marupudi, Neena ^{[1
]}

Mody, Rajen ^{[1
]}

Morgan, Meredith ^{[1
]}

Mota, Mateus ^{[1
]}

Muraszko, Karin ^{[1
]}

Mueller, Sabine ^{[15
,19
]}

Natarajan, Siva Kumar ^{[1
]}

Nazarian, Javad ^{[13
,31
]}

Niculcea, Michael ^{[1
]}

Nuechterlein, Nicholas ^{[1
,20
]}

Okada, Hideho ^{[1
,15
]}

机构：

[1] Univ Michigan, Ann Arbor, MI 48109 USA

[2] Clin Univ Navarra, Navarra, Spain

[3] Baylor Coll Med, Houston, TX 77030 USA

[4] Dana Faber Canc Inst, Boston, MA 02215 USA

[5] Stanford Univ, Stanford, CA 94305 USA

[6] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[7] Daegu Gyeongbuk Inst Sci & Technol, Daegu 42988, South Korea

[8] Univ Newcastle, Callaghan, NSW 2308, Australia

[9] Hosp Sick Children, Toronto, ON M5G 1E8, Canada

[10] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

[11] Princess Maxima Ctr, NL-3584 CS Utrecht, Netherlands

[12] Inst Canc Res, Div Mol Pathol, London SM2 5NG, England

[13] Childrens Natl Hosp, Washington, DC 20010 USA

[14] Johns Hopkins Univ, Baltimore, MD 21205 USA

[15] Univ Calif San Francisco, San Francisco, CA 94143 USA

[16] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA

[17] Univ Cincinnati, Cincinnati, OH 45229 USA

[18] St Jude, Memphis, TN 38105 USA

[19] Univ Zurich, Parker Inst Canc Immunotherapy, Zurich, Switzerland

[20] NIH, Bldg 10, Bethesda, MD 20892 USA

[21] Duke Univ, Durham, NC 27708 USA

[22] Advocate Childrens Hosp, Park Ridge, IL 60068 USA

[23] Weill Cornell Med, New York Presbyterian, New York, NY 10065 USA

[24] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA

[25] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Med Ctr, Dept Neurol, New York, NY 10032 USA

[26] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA

[27] Univ Colorado Denver, Denver, CO 80204 USA

[28] Univ New South Wales, Fac Med & Hlth, Sch Biomed Sci, Sydney, NSW, Australia

[29] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA

[30] Childrens Mercy, Kansas City, MO 64108 USA

[31] Univ Zurich, Zurich, Switzerland

来源：

CANCER CELL | 2024年 / 42卷 / 01期

基金：

美国国家卫生研究院;

关键词：

HIGH-GRADE; CELLS; GAIN;

D O I：

10.1016/j.ccell.2023.11.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recent clinical trials for H3K27-altered diffuse midline gliomas (DMGs) have shown much promise. We present a consensus roadmap and identify three major barriers: (1) refinement of experimental models to include immune and brain-specific components; (2) collaboration among researchers, clinicians, and industry to integrate patient-derived data through sharing, transparency, and regulatory considerations; and (3) streamlining clinical efforts including biopsy, CNS-drug delivery, endpoint determination, and response monitoring. We highlight the importance of comprehensive collaboration to advance the understanding, diagnostics, and therapeutics for DMGs.

引用

页码：1 / 5

页数：5

共 50 条

[31] UNCOVERING THE FACTS IN DIFFUSE MIDLINE GLIOMA (DMG)
Holliday, Holly
Ehteda, Anahid
Khan, Aaminah
Krug, Brian
Rouaen, Jourdin R. C.
Jayatilleke, Nisitha
Mayoh, Chelsea
Vittorio, Orazio
Jabado, Nada
Tsoli, Maria
Ziegler, David S.
NEURO-ONCOLOGY, 2022, 24 : 18 - 18
[32] Prognostic factors analysis of diffuse midline glioma
Jing Jiang
Wen-bin Li
Shao-wen Xiao
Journal of Neuro-Oncology, 2024, 167 : 285 - 292
[33] INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY (IMI) FOR ADULTS WITH DIFFUSE MIDLINE GLIOMA OR DIFFUSE HEMISPHERIC GLIOMA
Van Gool, Stefaan
Kosmal, Jennifer
van de Vliet, Peter
Kampers, Linde
Stuecker, Wilfried
NEURO-ONCOLOGY, 2024, 26
[34] Interdisciplinary care of children with diffuse midline glioma
Coleman, Christina
Chen, Katherine
Lu, Alex
Seashore, Elizabeth
Stoller, Schuyler
Davis, Taron
Braunstein, Steve
Gupta, Nalin
Mueller, Sabine
NEOPLASIA, 2023, 35
[35] The promise of metabolic imaging in diffuse midline glioma
Lovibond, Samantha
Gewirtz, Alexandra N.
Pasquini, Luca
Krebs, Simone
Graham, Maya S.
NEOPLASIA, 2023, 39
[36] Vanishing Contrast Enhancement of a Diffuse Midline Glioma
Depond, Charles Champeaux
Metellus, Philippe
Gross, Emmanuel
Appay, Romain
NEUROPATHOLOGY, 2025,
[37] NEW PRECLINICAL MODELS FOR DIFFUSE MIDLINE GLIOMA
Klenner, Marbod
Freidel, Pia
Filbin, Mariella G.
Beck, Alexander
NEURO-ONCOLOGY, 2022, 24 : 27 - 27
[38] Vaccine shows promise in diffuse midline glioma
Wood, Heather
NATURE REVIEWS NEUROLOGY, 2023, 19 (11) : 638 - 638
[39] Clinicohistoradiological and surgical outcome in diffuse midline glioma
Suman, Arvind Kumar
Das, Rakesh
Karath, Vishwa
Kolpakwar, Swapnil
Syed, Tazeem Fathima
Bhattacharjee, Suchanda
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
[40] Clinicohistoradiological and surgical outcome in diffuse midline glioma
Arvind Kumar Suman
Suchanda Bhattacharjee
Megha S. Uppin
Syed Tazeem Fathima
Child's Nervous System, 2024, 40 : 65 - 71

← 1 2 3 4 5 →